Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Uveitic macular edema is swelling of the macula caused by inflammation from uveitis. Inflammation disrupts the blood-retinal barrier, allowing fluid to collect within or under the retina, often in a cystoid pattern. It is a common cause of reduced central vision in people with uveitis. Treatment focuses on controlling inflammation and monitoring the macula over time.
read more about uveitic-macular-edema ...Macular edema in uveitis is driven by inflammatory mediators that increase vascular leakage. It can occur with anterior, intermediate, posterior, or panuveitis and may persist even when the eye looks quieter. Risk also increases after intraocular surgery or with uncontrolled inflammation.
Symptoms typically involve central vision and may fluctuate with inflammation. Some people notice distortion rather than simple blur. Because the macula supports fine detail, even mild swelling can be noticeable.
Optical coherence tomography (OCT) is the main test used to confirm and measure macular edema. Fluorescein angiography may be used to show leakage patterns and help distinguish inflammatory edema from other causes. Clinicians also look for active inflammation and rule out infection or structural causes that change treatment. Serial imaging helps track response to therapy.
Treatment is individualized and typically starts with controlling the underlying uveitis. Options include corticosteroids (topical, periocular, intravitreal, or systemic) and steroid-sparing immunomodulatory therapy for recurrent disease. Some cases may use nonsteroidal anti-inflammatory drugs or biologic agents depending on the uveitis type. Anti-VEGF injections may be considered in selected situations, but controlling inflammation remains central.
Often, yes. Uveitis-related macular edema commonly presents as cystoid macular edema on OCT. The term uveitic macular edema emphasizes that inflammation is the main driver.
OCT is the most common test because it shows retinal swelling and cystic spaces in detail. Fluorescein angiography can provide additional information about leakage and vascular involvement. Your clinician may repeat imaging to monitor change over time.
It can be reversible when treated early, especially if inflammation is controlled. Chronic, untreated edema can damage retinal layers and reduce visual recovery. Ongoing follow-up helps reduce this risk.
Yes. Recurrence can happen if uveitis flares or if treatment is tapered too quickly. Long-term inflammation control and regular monitoring help limit relapses and protect vision.
Treatment of Uveitic Macular Edema: A Review. Massenzio L, et al. https://pubmed.ncbi.nlm.nih.gov/40747994/. Date Accessed: February 19, 2026.
Update on the Management of Uveitic Macular Edema. Teper SJ, et al. https://pubmed.ncbi.nlm.nih.gov/34575244/. Date Accessed: February 19, 2026.
Efficacy and Safety of Single-Dose Intravitreal Dexamethasone Implant for Uveitic Macular Edema: A Systematic Review and Meta-Analysis. Fan S, et al. https://pmc.ncbi.nlm.nih.gov/articles/PMC9982842/. Date Accessed: February 19, 2026.
Systemic and Intravitreal Pharmacotherapy for Uveitic Macular Edema: An American Academy of Ophthalmology Report. Smith JR, et al. https://pubmed.ncbi.nlm.nih.gov/38647511/. Date Accessed: February 19, 2026.
Corticosteroids for the Management of Uveitic Macular Edema: A Comprehensive Review. Jimenez VL, et al. https://pubmed.ncbi.nlm.nih.gov/39235342/. Date Accessed: February 19, 2026.